Premier Alternatives

AccurKardia

New York, NY · Founded 2019 · Privately Held (backing)

Developer of an ECG (Electrocardiogram)-based diagnostics software platform intended to enhance interpretation of electrocardiogram data for improved detection of cardiovascular and metabolic… AccurKardia is based in New York, NY and was founded in 2019. It has raised $9 million across 1 recorded round; the latest was a $4.1 million seed round in Aug 2022.

Last price · $/share
—
Implied valuation
—
Total raised
$9.0M
Last round
Seed Round
Aug 2022
How much has AccurKardia raised?
$9.0Macross 1 recorded rounds · Aug 2022 – Aug 2022

Most recently, AccurKardia raised $4.1M in its Seed Round (Aug 2022).

Free account
More of AccurKardia with a free account
  • ·Watch AccurKardia: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

AccurKardia round by round

1 rounds
Aug 2022Seed Round$4.1MSEC filing▮
41 investors participated

How much has AccurKardia raised?

AccurKardia has raised $9 million in total; 1 of its rounds is on record. The largest on record was a $4.1 million seed round in Aug 2022.

AccurKardia has filed 1 Form D with the SEC, most recently in Jun 2023 ($4.1 million sold to 41 investors).

AccurKardia investors

3 investors are on record for AccurKardia, including MedTech Innovator, Mayo Clinic Platform and Popular. The seed round in Aug 2022 drew 41 investors.

For fundraisers
Raising for a company like AccurKardia?

3 investors have backed AccurKardia.

See all 3 investors →

Frequently asked about AccurKardia

How much has AccurKardia raised?
AccurKardia has raised $9.0M in total across 1 recorded funding rounds.
When was AccurKardia's last funding round?
AccurKardia's most recent recorded round was Seed Round in Aug 2022, raising $4.1M.